查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1470805

感染疾病诊断市场：按产品、技术、测试类型、样本、应用和最终用户划分 - 全球预测 2024-2030

Infectious Disease Diagnostic Market by Product (Instruments, Reagents, Software & Services), Technology (Biochemical Technology, Conventional Technology, Molecular Technology), Testing Type, Sample, Application, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年感染疾病诊断市场规模为247.6亿美元，预计2024年将达264.4亿美元，2030年将达405.3亿美元，复合年增长率为7.29%。

感染疾病诊断产品旨在检测和识别引起人类感染疾病的病原体。这些诊断透过准确、及时地识别传染源以及及时、适当的临床管理，在医疗保健中发挥重要作用。诊断感染疾病的诊断方法包括培养方法、分子诊断方法、血清学测试、基于抗原的测试和次世代定序方法，它有助于实施感染控制措施，以防止病原体在医疗机构内传播。近年来，由于感染疾病的爆发，迫切需要高可靠性的诊断试剂。此外，全球医疗保健支出的增加和实验室基础设施的改善也促进了感染疾病诊断解决方案的普及。此外，政府对创新诊断解决方案的措施和监管部门的核准正在扩大新感染疾病解决方案的可用性。然而，与先进诊断技术相关的高成本可能会限制其在成本敏感地区的采用。新兴市场缺乏熟练的专业人员来操作先进的诊断设备可能会限制我们产品的普及。然而，随着先进技术的整合增强了复杂诊断测试的资料分析和解释，诊断测试的产出正在改善。此外，快速 PCR 系统和次世代定序等诊断技术的不断进步，透过提供更快、更准确的结果，推动了对感染疾病诊断产品的需求。

主要市场统计
基准年[2023] 247.6亿美元
预测年份 [2024] 264.4亿美元
预测年份 [2030] 405.3亿美元
复合年增长率（%） 7.29%

产品感染疾病诊断分析仪器应用的演变

分析设备包括用于诊断感染疾病的各种分析设备，从基本的检测设备到先进的诊断设备，如PCR系统、免疫测量、微生物培养和分子诊断平台。测试设备对于需要实验室测试以获得快速可靠结果的实验室、医院和诊所至关重要。试剂构成用于检测临床样本中病原体的生化物质或混合物。试剂包括用于PCR测试的引子、探针、酵素、缓衝液、用于免疫测量的抗体以及用于细菌生长的各种培养基。不同的疾病需要特定的试剂来进行准确的检测，并且偏好根据感兴趣的病原体而变化。软体和服务包括资料分析软体、整合各种诊断平台的互通性解决方案、实验室管理、技术支援和咨询服务。软体和服务对于实际解释诊断测试并将诊断资料与患者记录整合至关重要。提供者通常更喜欢易于使用、强大的资料分析功能以及与现有系统相容的软体。

测试类型：新兴的便利和紧急应用现场护理 (PoC) 测试

实验室测试分析样本以检测感染疾病，并在受控环境中使用特殊设备进行。实验室测试通常被认为是黄金标准，因为其准确性高且能够提供全面的结果。实验室检测的偏好源于需要准确和详细的诊断来指南有效的治疗计划。准确度高、分析全面的实验室检测是确诊的更可靠选择，适用于时间限制较少的复杂病例。另一方面，护理点 (PoC) 测试是在患者护理点或附近进行的诊断测试。 PoC 测试的主要优点是其方便且快速的结果，这对于临床决策至关重要。 PoC 测试可以使用可携式设备或快速检测套组（例如横向流动测定）进行，并且在资源有限的环境或需要即时结果的情况下需要。

应用越来越多地使用疾病诊断套件来诊断病毒感染

细菌感染疾病的诊断涉及识别引起结核病、肺炎和尿道感染等疾病的病原菌。医疗机构对细菌诊断的需求量很大，快速诊断工具对于及时治疗至关重要，并且可以减少感染疾病的传播。心血管感染疾病的诊断包括检测致病菌的分子和血清学检查。中枢神经系统 (CNS)感染疾病（包括脑膜炎和脑炎）可能很严重，需要及时、准确的诊断。真菌感染疾病的诊断对于免疫力缺乏的患者至关重要，因为念珠菌症和曲菌症等感染疾病会危及生命。多种诊断测试用于诊断真菌疾病，从传统培养方法到先进的分子诊断平台。 HIV、HPV、披衣菌感染和淋病等性行为感染传染病 (STD) 的诊断对于公共卫生至关重要。这些诊断剂非常需要，因为它们影响许多人，并对生殖健康产生严重影响。病毒诊断涵盖流感、肝炎和新出现的病原体等多种疾病。

最终用户：感染疾病诊断产品在医院的普及

诊断实验室是进行传染病检查的专业设施。需要高通量系统、扩充性和全面的测试选单来满足各种诊断需求。诊断实验室优先考虑自动化平台、与实验室资讯系统的整合以及处理大量检体的经济有效的测试。医院是治疗感染疾病患者的关键点。医院需要快速、准确且易于整合到内部患者照护工作流程中的诊断工具。医院正在寻求诊断解决方案，例如就地检验设备，以最大限度地缩短诊断时间，以改善患者管理和隔离通讯协定。研究机构专注于感染疾病的研究，以了解其本质并开发新的诊断技术。研究机构需要复杂而灵敏的设备来在分子层面上检测和研究病原体。研究机构对最尖端科技、检测能力的多样性以及针对不同病原体的多种检测方法感兴趣。

区域洞察

由于感染疾病的传播、诊断技术的进步以及早期疾病检测意识的提高，美洲的感染疾病诊断市场正在经历快速成长。先进技术的采用、成熟的医疗基础设施以及众多供应商的存在正在为美洲的感染疾病诊断市场做出贡献。欧盟 (EU) 法规和复杂的医疗保健系统对欧洲市场产生重大影响。欧盟国家正在大力投资研究和创新，这与客户在疾病预防和控制方面采取的积极行动产生共鸣，加速先进诊断技术开发的倡议就是例证。中东市场以高医疗保健支出和引进高科技诊断设备为导向，特别是在波湾合作理事会（GCC）国家。在非洲，对容易取得且负担得起的诊断试剂的需求不断增长，以对抗爱滋病毒/爱滋病、结核病和疟疾等流行感染疾病，对感染疾病诊断产品的需求也不断增长。由于人口众多、医疗费用不断上涨，亚太地区的感染疾病诊断市场正迅速扩大。政府对医疗改革的关注和国内公司的崛起正在促进感染疾病诊断的成长。

FPNV定位矩阵

FPNV 定位矩阵对于评估感染疾病诊断市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对感染疾病诊断市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.感染疾病诊断市场的市场规模和预测是多少？

2.在感染疾病诊断市场的预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.感染疾病诊断市场的技术趋势和法规结构是什么？

4.感染疾病诊断市场主要厂商的市场占有率为何？

5.进入感染疾病诊断市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 感染疾病的全球盛行率不断上升和週期性爆发
      • 重点从集中式临床实验室转向分散式临床实验室
      • 政府在感染疾病控制和预防方面的支持性努力和投资
    • 抑制因素
      • 报销不足和医疗费用上涨限制了新诊断技术的使用
    • 机会
      • 感染疾病诊断套件和解决方案的进展
      • 推出居家医疗的感染疾病诊断套件
    • 任务
      • 准确性问题和缺乏熟练的专业人员
  • 市场区隔分析
    • 产品：感染疾病诊断分析仪器应用进展
    • 测试类型：更多采用现场护理 (PoC) 测试，以实现便利和紧急应用
    • 应用：增加使用疾病诊断套件诊断病毒感染
    • 最终用户：感染疾病诊断产品在医院的普及
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章感染疾病诊断市场：副产品

  • 装置
  • 试剂
  • 软体和服务

第七章感染疾病诊断市场：依技术分类

  • 生化技术
  • 常规技术
  • 分子技术

第八章感染疾病诊断市场检测类型

  • 临床检查
  • 概念验证测试

第九章感染疾病诊断市场样本

  • 血液、血浆、血清
  • 尿

第十章感染疾病诊断市场：依应用分类

  • 细菌感染
  • 心血管感染疾病
  • 中枢神经系统感染疾病
  • 霉菌感染疾病
  • 性行为感染传染病
  • 病毒感染

第十一章感染疾病诊断市场：依最终用户分类

  • 诊断实验室
  • 医院
  • 调查机构

第十二章 北美和南美感染疾病诊断市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太地区感染疾病诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章欧洲、中东和非洲感染疾病诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Medix Biochemica 收购美国ViroStat 以扩大感染疾病抗体供应
    • Oxford Nanopore 与生物梅里埃签署策略合作伙伴协议，开发创新感染疾病诊断
    • Thermo Fisher Scientific 在印度推出感染疾病检测的 PCR套件
  • 战略分析和建议

第16章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-4316E4E89510

[183 Pages Report] The Infectious Disease Diagnostic Market size was estimated at USD 24.76 billion in 2023 and expected to reach USD 26.44 billion in 2024, at a CAGR 7.29% to reach USD 40.53 billion by 2030.

Infectious disease diagnostics products are designed to detect and identify pathogens that cause human infections. These diagnostics play a critical role in healthcare by facilitating the accurate and timely recognition of infectious agents, thus ensuring prompt and appropriate clinical management. The modalities for infectious disease diagnostics include culture techniques, molecular diagnostics, serology, antigen-based tests, and next-generation sequencing for guiding treatment decisions, monitoring disease outbreaks, and implementing infection control measures to prevent the spread of pathogens within communities and healthcare settings. In recent years, outbreaks of infectious diseases have resulted in an urgent need for reliable diagnostics. In addition, growth in healthcare spending and improvements in laboratory infrastructure globally contribute to the penetration of infectious disease diagnostic solutions. Moreover, government initiatives and regulatory approvals for innovative diagnostic solutions have expanded the availability of novel infectious disease diagnostic solutions. However, high costs associated with advanced diagnostic technologies could limit adoption in cost-sensitive regions. The lack of skilled professionals in emerging markets to operate sophisticated diagnostic equipment may restrict product penetration. Nevertheless, the integration of advanced technologies for enhanced data analysis and interpretation of complex diagnostic tests has enhanced the outputs of diagnostic tests. In addition, continuous development in diagnostic technologies, including rapid PCR systems and next-generation sequencing, drives the demand for infectious disease diagnostics products by offering quicker and more accurate results.

KEY MARKET STATISTICS
Base Year [2023] USD 24.76 billion
Estimated Year [2024] USD 26.44 billion
Forecast Year [2030] USD 40.53 billion
CAGR (%) 7.29%

Product: Advancing applications of analytical instruments for infectious disease diagnostics

The instruments include various analytical devices for diagnosing infectious diseases, ranging from essential laboratory equipment to sophisticated diagnostic machines such as PCR systems, immunoassays, microbiology cultures, and molecular diagnostics platforms. Instruments are crucial for laboratories, hospitals, and clinics requiring in-house testing for fast and reliable results. Reagents constitute the biochemical substances and mixtures used to detect pathogens in clinical samples. Reagents include primers, probes, enzymes, and buffers for PCR tests, antibodies for immunoassays, and various culture media for bacterial growth. Different diseases require specific reagents for accurate detection; hence, the preference varies based on the pathogen of interest. Software & services include data analysis software, interoperability solutions for integrating various diagnostic platforms, and services such as lab management, technical support, and consultancy. Software and services are critical for practically interpreting diagnostic tests and integrating diagnostics data with patient records. Providers usually prefer software that offers ease of use, robust data analysis capabilities, and compatibility with existing systems.

Testing Type: Emerging adoption of Point-of-Care (PoC) testing for convenience and emergency applications

Laboratory testing analyzes samples to detect infectious diseases, which is done in a controlled environment with specialized equipment. Laboratory testing is often considered the gold standard due to its high accuracy and ability to provide comprehensive results. The preference for laboratory testing arises from the need for precise and detailed diagnostics that can guide effective treatment plans. With its enhanced precision and capacity for comprehensive analysis, laboratory testing is the more reliable option for definitive diagnostics and is suited for complex cases with less time sensitivity. On the other hand, Point-of-Care (PoC) testing is diagnostic testing performed at or near the site of patient care. The critical advantage of PoC testing is its convenience and the rapidity with which results can be obtained, which is essential in clinical decision-making. PoC testing can be performed with portable instruments or simple test kits, such as lateral flow assays, and is necessary in resource-limited settings or situations where immediate results are required.

Application: Increasing use of disease diagnosis kits to diagnose viral infections

Diagnostics for bacterial infections involve the identification of pathogenic bacteria that can cause disorders such as tuberculosis, pneumonia, and urinary tract infections. Need-based preference for bacterial diagnostics is high in healthcare settings where rapid diagnostic tools are essential for timely treatment, thus reducing the spread of infections. Diagnostics for cardiovascular infections involve molecular tests and serology testing to detect pathogenic organisms. Central Nervous System (CNS) infections can include meningitis and encephalitis and require rapid and accurate diagnostics due to their potential severity. Fungal infection diagnostics are essential for immunocompromised patients, where infections including candidiasis and aspergillosis can be life-threatening. Diagnostic tests range from traditional culture methods to advanced molecular diagnostic platforms to diagnose fungal disorders. Diagnostics for sexually transmitted diseases (STDs) such as HIV, HPV, chlamydia, and gonorrhea are crucial for public health. These diagnostics have a high need-based preference because they affect a large demographic and can have serious reproductive health consequences. Viral diagnostics cover various diseases, including influenza, hepatitis, and emerging pathogens.

End-User: Penetration of infectious disease diagnosis products in hospitals

Diagnostic laboratories are specialized facilities where infectious disease tests are conducted. They require high throughput systems, scalability, and comprehensive test menus to cater to varied diagnostic needs. Diagnostic laboratories prioritize automated platforms, integration with laboratory information systems, and cost-effective testing to handle high volumes of samples. Hospitals form a critical point of care for patients suffering from infectious diseases. Hospitals require diagnostic tools that are fast, accurate, and can be easily integrated into the patient care workflow within their facilities. Hospitals seek diagnostic solutions that minimize time to diagnosis to improve patient management and isolation protocols, such as point-of-care testing devices. Research institutes focus on studying infectious diseases to understand their nature and develop new diagnostic technologies. Research institutes require sophisticated and susceptible equipment to detect and study pathogens at a molecular level. Research institutes are interested in cutting-edge technology, versatility in testing capabilities, and access to various assays for different pathogens.

Regional Insights

The infectious disease diagnostic market in the Americas is observing rapid growth due to the increasing prevalence of infectious diseases, advanced diagnostic technologies, and growing awareness of early disease detection. The adoption of advanced technologies, well-established healthcare infrastructure, and the presence of the majority of vendors contribute to the infectious disease diagnostic market in the Americas. European Union's (EU) regulations and a sophisticated healthcare system largely influence Europe's market. EU countries invest heavily in research and innovation, exemplified by initiatives to foster the development of advanced diagnostics and resonate with proactive customer behavior toward disease prevention and management. The Middle East market is directed by significant healthcare spending and the adoption of high-tech diagnostic equipment, particularly in Gulf Cooperation Council (GCC) countries. The need for accessible and affordable diagnostics to combat prevalent infectious diseases such as HIV/AIDS, tuberculosis, and malaria has improved the need for infectious disease diagnosis products in Africa. The infectious disease diagnostic market in the Asia-Pacific is expanding rapidly due to its large population and increased healthcare expenditure. The government's focus on healthcare reform and the rise of domestic companies contribute to the growth of infectious disease diagnostics.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Infectious Disease Diagnostic Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Infectious Disease Diagnostic Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Infectious Disease Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaptive Biotechnologies Corporation, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Techne Corporation, bioMerieux SA, Cardinal Health Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., GE Healthcare, Grifols, S.A., Hologic Inc., Illumina, Inc., Johnson & Johnson Services, Inc., Konica Minolta, Inc., Labsystems Diagnostics Oy, Merck KGaA, Olympus Corporation, Perkin Elmer, Inc., Pfizer Inc., Qiagen N.V., Quest Diagnostics, Siemens Healthineers AG, Sysmex Corporation, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Infectious Disease Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments
    • Reagents
    • Software & Services
  • Technology
    • Biochemical Technology
    • Conventional Technology
    • Molecular Technology
  • Testing Type
    • Laboratory Testing
    • PoC Testing
  • Sample
    • Blood, Plasma, & Serum
    • Urine
  • Application
    • Bacterial Infection
    • Cardiovascular Infection
    • CNS Infection
    • Fungal Infection
    • Sexually Transmitted Disease
    • Viral Infection
  • End User
    • Diagnostic Laboratories
    • Hospital
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Infectious Disease Diagnostic Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Infectious Disease Diagnostic Market?

3. What are the technology trends and regulatory frameworks in the Infectious Disease Diagnostic Market?

4. What is the market share of the leading vendors in the Infectious Disease Diagnostic Market?

5. Which modes and strategic moves are suitable for entering the Infectious Disease Diagnostic Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing global prevalence and periodic outbreaks of infectious diseases
      • 5.1.1.2. Shift in focus towards decentralized point-of-care testing from centralized laboratories
      • 5.1.1.3. Supportive government initiatives and investments toward infectious disease control and prevention
    • 5.1.2. Restraints
      • 5.1.2.1. Inadequate reimbursements and rising healthcare costs limiting the use of novel diagnostic techniques
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in infectious disease diagnostics kits and solutions
      • 5.1.3.2. Emergence of infectious disease diagnostics kits for homecare settings
    • 5.1.4. Challenges
      • 5.1.4.1. Accuracy issues and limited availability of skilled professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Advancing applications of analytical instruments for infectious disease diagnostics
    • 5.2.2. Testing Type: Emerging adoption of Point-of-Care (PoC) testing for convenience and emergency applications
    • 5.2.3. Application: Increasing use of disease diagnosis kits to diagnose viral infections
    • 5.2.4. End-User: Penetration of infectious disease diagnosis products in hospitals
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Infectious Disease Diagnostic Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents
  • 6.4. Software & Services

7. Infectious Disease Diagnostic Market, by Technology

  • 7.1. Introduction
  • 7.2. Biochemical Technology
  • 7.3. Conventional Technology
  • 7.4. Molecular Technology

8. Infectious Disease Diagnostic Market, by Testing Type

  • 8.1. Introduction
  • 8.2. Laboratory Testing
  • 8.3. PoC Testing

9. Infectious Disease Diagnostic Market, by Sample

  • 9.1. Introduction
  • 9.2. Blood, Plasma, & Serum
  • 9.3. Urine

10. Infectious Disease Diagnostic Market, by Application

  • 10.1. Introduction
  • 10.2. Bacterial Infection
  • 10.3. Cardiovascular Infection
  • 10.4. CNS Infection
  • 10.5. Fungal Infection
  • 10.6. Sexually Transmitted Disease
  • 10.7. Viral Infection

11. Infectious Disease Diagnostic Market, by End User

  • 11.1. Introduction
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospital
  • 11.4. Research Institutes

12. Americas Infectious Disease Diagnostic Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Infectious Disease Diagnostic Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Infectious Disease Diagnostic Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Medix Biochemica Acquires US-Based ViroStat to Expand Infectious Diseases Antibody Offering
    • 15.3.2. Oxford Nanopore and bioMerieux to Enter into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics
    • 15.3.3. Thermo Fisher Scientific Launches PCR Kits for Infectious Disease Detection in India
  • 15.4. Strategy Analysis & Recommendation

16. Competitive Portfolio

  • 16.1. Key Company Profiles
  • 16.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. INFECTIOUS DISEASE DIAGNOSTIC MARKET RESEARCH PROCESS
  • FIGURE 2. INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INFECTIOUS DISEASE DIAGNOSTIC MARKET DYNAMICS
  • FIGURE 7. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 18. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 22. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 27. INFECTIOUS DISEASE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 28. INFECTIOUS DISEASE DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INFECTIOUS DISEASE DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BIOCHEMICAL TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BIOCHEMICAL TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MOLECULAR TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MOLECULAR TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, PLASMA, & SERUM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, PLASMA, & SERUM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY URINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY URINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CARDIOVASCULAR INFECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CARDIOVASCULAR INFECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CNS INFECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CNS INFECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 207. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 208. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 220. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 231. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 232. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 255. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 256. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 267. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 268. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 279. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 280. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 290. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 305. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 306. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 307. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 308. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2018-2023 (USD MILLION)
  • TABLE 312. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE, 2024-2030 (USD MILLION)
  • TABLE 313. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 314. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 315. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 316. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 317. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 318. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 20